litlas
ログインアカウント作成

Gordon C. Jayson

1994–2024 年に発表

89
論文数
18,633
被引用数
66
h 指数
86
i10 指数

被引用数

Gordon C. Jayson の年別被引用数1967 年: 被引用 1 件1993 年: 被引用 1 件1996 年: 被引用 5 件1997 年: 被引用 2 件1998 年: 被引用 11 件1999 年: 被引用 11 件2000 年: 被引用 10 件2001 年: 被引用 10 件2002 年: 被引用 18 件2003 年: 被引用 28 件2004 年: 被引用 46 件2005 年: 被引用 57 件2006 年: 被引用 127 件2007 年: 被引用 109 件2008 年: 被引用 99 件2009 年: 被引用 100 件2010 年: 被引用 119 件2011 年: 被引用 163 件2012 年: 被引用 173 件2013 年: 被引用 113 件2014 年: 被引用 149 件2015 年: 被引用 124 件2016 年: 被引用 169 件2017 年: 被引用 198 件2018 年: 被引用 170 件2019 年: 被引用 665 件2020 年: 被引用 687 件2021 年: 被引用 568 件2022 年: 被引用 484 件2023 年: 被引用 328 件2024 年: 被引用 462 件2025 年: 被引用 199 件2026 年: 被引用 8 件1968〜1992 年は被引用が無いため表示していません1994〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,571 件、この内訳の 20.4%中国: 引用元論文 927 件、この内訳の 12.1%イギリス: 引用元論文 763 件、この内訳の 9.9%イタリア: 引用元論文 438 件、この内訳の 5.7%ドイツ: 引用元論文 403 件、この内訳の 5.2%オランダ: 引用元論文 296 件、この内訳の 3.8%フランス: 引用元論文 289 件、この内訳の 3.8%カナダ: 引用元論文 275 件、この内訳の 3.6%オーストラリア: 引用元論文 211 件、この内訳の 2.7%スペイン: 引用元論文 197 件、この内訳の 2.6%日本: 引用元論文 192 件、この内訳の 2.5%インド: 引用元論文 153 件、この内訳の 2%
0%20.4%その他 25.7%

機関

分野

  • Medicine61.4%
  • Biochemistry, Genetics and Molecular Biology27.6%
  • Immunology and Microbiology2.4%
  • Engineering2.1%
  • Chemistry1.2%
  • Materials Science1.2%
  • その他4.1%

トピック

  • Ovarian cancer diagnosis and treatment8.4%
  • Radiomics and Machine Learning in Medical Imaging3.8%
  • PARP inhibition in cancer therapy3.6%
  • MRI in cancer diagnosis3.6%
  • Angiogenesis and VEGF in Cancer3.2%
  • Intraperitoneal and Appendiceal Malignancies2.3%
  • その他75.1%

共著者

全論文

検索で開く
  1. Ovarian cancer

    著者: Gordon C. Jayson, Elise C. Kohn, Henry C Kitchener, Jonathan A. Ledermann - The Lancet 2014 被引用: 1,873

  2. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

    著者: Sean Kehoe, Jane Hook, Matthew Nankivell, Gordon C. Jayson, Henry C Kitchener, Tito Lopes, David Luesley, Timothy Perren, Selina Bannoo, M Mascarenhas, Stephen Dobbs, Sharadah Essapen, Jeremy Twigg, Jonathan Herod, Glenn McCluggage, Mahesh Parmar, Ann-Marie Swart - The Lancet 2015 被引用: 1,395

  3. Imaging biomarker roadmap for cancer studies

    著者: James P.B. O’Connor, Eric O. Aboagye, Judith E. Adams, Hugo J.W.L. Aerts, Sally F. Barrington, Ambros J. Beer, Ronald Boellaard, Sarah E. Bohndiek, Michael Brady, Gina Brown, David L. Buckley, Thomas L. Chenevert, Laurence P. Clarke, Sandra Collette, Gary Cook, Nandita M. deSouza, John Dickson, Caroline Dive, Jeffrey L. Evelhoch, Corinne Faivre‐Finn, Ferdia A. Gallagher, Fiona J. Gilbert, Robert J. Gillies, Vicky Goh, John R. Griffiths, Ashley M. Groves, Steve Halligan, Adrian L. Harris, David J. Hawkes, Otto S. Hoekstra, Erich P. Huang, Brian Hutton, Edward F. Jackson, Gordon C. Jayson, Andrew Jones, Dow‐Mu Koh, Denis Lacombe, Philippe Lambin, Nathalie Lassau, Martin O. Leach, Ting-Yim Lee, Edward Leen, Jason S. Lewis, Yan Liu, Mark F. Lythgoe, Prakash Manoharan, Ross J. Maxwell, Kenneth A. Miles, Bruno Morgan, Steve Morris, Tony Ng, Anwar R. Padhani, Geoff J.M. Parker, Mike Partridge, Arvind P. Pathak, Andrew C. Peet, Shonit Punwani, Andrew R. Reynolds, Simon P. Robinson, Lalitha Shankar, Ricky A. Sharma, Dmitry Soloviev, Sigrid Stroobants, Daniel C. Sullivan, Stuart A. Taylor, Paul S. Tofts, Gillian M. Tozer, Marcel van Herk, Simon Walker‐Samuel, James Wason, Kaye J. Williams, Paul Workman, Thomas E. Yankeelov, Kevin M. Brindle, Lisa M. McShane, Alan Jackson, John C. Waterton - Nature Reviews Clinical Oncology 2016 被引用: 1,078

  4. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

    著者: Amit M. Oza, Adrian Cook, Jacobus Pfisterer, Andrew Embleton-Thirsk, Jonathan A. Ledermann, Éric Pujade-Lauraine, Gunnar B. Kristensen, Mark S. Carey, Philip Beale, Andrés Cervantes, Tjoung‐Won Park‐Simon, Gordon Rustin, Florence Joly, Mansoor Raza Mirza, Marie Plante, Michael Quinn, Andrés Poveda, Gordon C. Jayson, Dan Stark, Ann Marie Swart, Laura Farrelly, Richard Kaplan, Mahesh Parmar, Timothy Perren - The Lancet Oncology 2015 被引用: 867

  5. Antiangiogenic therapy in oncology: current status and future directions

    著者: Gordon C. Jayson, Robert S. Kerbel, Lee M. Ellis, Adrian L. Harris - The Lancet 2016 被引用: 836

  6. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

    著者: Mahesh Parmar, Jonathan A. Ledermann, Nicoletta Colombo, Andreas du Bois, Delaloye Jf, Gunnar B. Kristensen, Sarah Wheeler, Ann Marie Swart, W. Qian, Valter Torri, Irene Floriani, Gordon C. Jayson, Alan Lamont, C. Tropé - The Lancet 2003 被引用: 1,197

  7. Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

    著者: Gordon Rustin, Maria EL van der Burg, Clare Griffin, David Guthrie, Alan Lamont, Gordon C. Jayson, Gunnar B. Kristensen, César Mediola, Corneel Coens, Wendi Qian, Mahesh Parmar, Ann Marie Swart - The Lancet 2010 被引用: 594

  8. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

    著者: Ignace Vergote, Corneel Coens, Matthew Nankivell, Gunnar B. Kristensen, Mahesh Parmar, Tom Ehlen, Gordon C. Jayson, Nick Johnson, Ann Marie Swart, René H.M. Verheijen, W. Glenn McCluggage, Timothy Perren, Pierluigi Benedetti Panici, Gemma G. Kenter, Antonio Casado, César Mendiola, Gavin Stuart, N.S. Reed, Sean Kehoe, Claes Tropé G., Stephen Dobbs, Sharadah Essapen, P. Hoskins, John Green, Edward D. Gilby, Marchien van Baal, Jeremy Twigg, Maria E.L. van der Burg, Keith Godfrey, Ángel J. Lacave, Roberto Angioli, Rahul Nath, K. Chin, Charles Redman, Robert Lotocki, Adeola Olaitan, Berit Jul Mosgaard, Gordon Rustin, Thomas Ind, Mojca Persic, Martin Hogg, Jacobus van der Velden, Jonathan A. Ledermann, Peter Sykes Peter Sykes, Krishnawam Madhavan, Päivi Kannisto, V Hird, Anthony C. Evans, R. Sandvei R., Philippe Gauthier, Derek Cruickshank, P.B. Ottevanger, Sheila E. Pearson, Henry C Kitchener, Marcia Hall, Paul Bessette, S. Pecorelli, Eva Gerdin, Tito Lopes, Andrew Fish, Clare Barlow, Koen Van Eygen, Anne Floquet, Bengt Tholander, Nurdan Gül, Robert Gornall, David Luesley, P. H. Kirwan, Paul Symonds, Richard Henry, David Poole, Ian McNeish, M A Hocking, Al Sammaraie, P Speiser, Éric Leblanc, J.A. Green, C Fernández Oliveira, Robert Grimshaw, Paolo Zola, David E. Parkin, David Luesley, Martin Lamb, Anne Hong, Alan Gillespie, Abdel Hamid, Ahmed Ahmed, Marie Plante, B. De Valk, A Nordin, Andrew R. Clamp, D Díaz Pérez, Graham Dark, Michelle Ferguson, Carol MacGregor, G. Skailes, Rachel Jones, Alan Gillespie, G. Cawdell, Simon Leeson ほか 43 名 - The Lancet Oncology 2018 被引用: 306

  9. Molecular phenotyping of a UK population: defining the human serum metabolome

    著者: Warwick B. Dunn, Wanchang Lin, David Broadhurst, Paul Begley, Marie Brown, Eva Zelena, Andrew A. Vaughan, Antony Halsall, Nadine Harding, Joshua Knowles, Sue Francis‐McIntyre, Andy Tseng, David I. Ellis, Steve O’Hagan, Gill Aarons, Boben Benjamin, Stephen Chew-Graham, Carly Moseley, Paula W. Potter, Catherine Winder, Catherine Potts, Paula Thornton, Catriona McWhirter, Mohammed Zubair, Martin Pan, Alistair Burns, J. CRUICKSHANK, Gordon C. Jayson, Nitin Purandare, Frederick C. W. Wu, Joe D. Finn, John N. Haselden, Andrew W. Nicholls, Ian D. Wilson, Royston Goodacre, Douglas B. Kell - Metabolomics 2014 被引用: 261

  10. Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI

    著者: Geoff J.M. Parker, Caleb Roberts, Andrew Macdonald, Giovanni A. Buonaccorsi, Sue Cheung, David L. Buckley, Alan Jackson, Yvonne Watson, Karen Davies, Gordon C. Jayson - Magnetic Resonance in Medicine 2006 被引用: 664

  11. Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial

    著者: Víctor Moreno, Maria-Pilar Barretina-Ginesta, Jesús García-Donás, Gordon C. Jayson, Patricia Roxburgh, Raúl Márquez Vázquez, Agnieszka Michael, Antonio Antón-Torres, R. H. Brown, David Krige, Brian Champion, Iain A. McNeish - Journal for ImmunoTherapy of Cancer 2021 被引用: 54

  12. Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma

    著者: P. Vasey, Gordon C. Jayson, Amanda Gordon, Hani Gabra, Robert L. Coleman, R. Atkinson, David E. Parkin, J. P. Paul, A. Hay, Stuart Kaye, On behalf of the Scottish Gynaecological Cancer Trials Group - JNCI Journal of the National Cancer Institute 2004 被引用: 638

  13. Biomarkers of angiogenesis and their role in the development of VEGF inhibitors

    著者: Nishanth Murukesh, Caroline Dive, Gordon C. Jayson - British Journal of Cancer 2009 被引用: 239

  14. Objective responses to first-line neoadjuvant carboplatin–paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial

    著者: Robert D. Morgan, Iain A. McNeish, Adrian Cook, Elizabeth C James, Rosemary Lord, G. Dark, Rosalind Glasspool, Jonathan Krell, Christine Parkinson, Christopher Poole, Marcia Hall, Dolores Gallardo‐Rincón, Michelle Lockley, Sharadah Essapen, Jeff Summers, Anjana Anand, Abel Zachariah, Sarah Williams, Rachel Jones, Kate Scatchard, Axel Walther, Jae‐Weon Kim, Sudha Sundar, Gordon C. Jayson, Jonathan A. Ledermann, Andrew R. Clamp - The Lancet Oncology 2020 被引用: 63

  15. Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study

    著者: Robert D. Morgan, Andrew R. Clamp, Bethany M. Barnes, Kirsten M. Timms, Hélene Schlecht, Laura Yarram-Smith, Yvonne Wallis, Mikel Valganon-Petrizan, Suzanne MacMahon, Rhian White, Siân Morgan, Sarah McKenna, Emma Hudson, Laura A. Tookman, Angela George, Ranjit Manchanda, Sudha Sundar, Shibani Nicum, James D. Brenton, Rebecca Kristeleit, Susana Banerjee, Iain A. McNeish, Jonathan A. Ledermann, Stephen S. Taylor, D. Gareth Evans, Gordon C. Jayson - International Journal of Gynecological Cancer 2023 被引用: 19

  16. A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity

    著者: Louisa Nelson, Anthony Tighe, Anya Golder, Samantha Littler, Björn Bakker, Daniela Moralli, Syed Murtuza Baker, Ian J. Donaldson, Diana C.J. Spierings, René Wardenaar, Bethanie Neale, George J. Burghel, Brett Winter‐Roach, Richard J. Edmondson, Andrew R. Clamp, Gordon C. Jayson, Sudha Desai, Catherine Green, Andrew Hayes, Floris Foijer, Robert D. Morgan, Stephen S. Taylor - Nature Communications 2020 被引用: 101

  17. Endothelial Heparan Sulfate 6-O-Sulfation Levels Regulate Angiogenic Responses of Endothelial Cells to Fibroblast Growth Factor 2 and Vascular Endothelial Growth Factor

    著者: Cristina Ferreras, Graham Rushton, Claire L. Cole, Muhammad Babur, Brian A. Telfer, Toin H. Van Kuppevelt, John M. Gardiner, Kaye J. Williams, Gordon C. Jayson, Egle Avizienyte - Journal of Biological Chemistry 2012 被引用: 85

  18. First-Line Management of Advanced High-Grade Serous Ovarian Cancer

    著者: Reem D. Mahmood, Robert D. Morgan, Richard J. Edmondson, Andrew R. Clamp, Gordon C. Jayson - Current Oncology Reports 2020 被引用: 66

  19. Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer

    著者: Shibani Nicum, Naomi McGregor, Rachel Austin, Linda Collins, Susan Dutton, Iain A. McNeish, Rosalind Glasspool, Marcia Hall, René L. Roux, Agnieszka Michael, Andrew R. Clamp, Gordon C. Jayson, Rebecca Kristeleit, Susana Banerjee, Anita Mansouri - British Journal of Cancer 2024 被引用: 24

  20. Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies

    著者: James P.B. O’Connor, Alan Jackson, Geoff J.M. Parker, Caleb Roberts, Gordon C. Jayson - Nature Reviews Clinical Oncology 2012 被引用: 350

  21. Intra-tumoural microvessel density in human solid tumours

    著者: Jurjees Hasan, Richard Byers, Gordon C. Jayson - British Journal of Cancer 2002 被引用: 308

  22. The Current and Future Management of Malignant Ascites

    著者: Ed Smith, Gordon C. Jayson - Clinical Oncology 2003 被引用: 167

  23. Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

    著者: Yvette Drew, Jonathan A. Ledermann, Geoff Hall, Daniel Rea, Rosalind Glasspool, Martin Highley, Gordon C. Jayson, Julieann Sludden, J. C. Murray, David Jamieson, Sarah Halford, Gary D Acton, Zoe Backholer, Raffaella Mangano, Alan V. Boddy, Nicola J. Curtin, Ruth Plummer - British Journal of Cancer 2016 被引用: 163

  24. Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer

    著者: Claire L. Cole, S. Lau, Alison Backen, Andrew R. Clamp, Graham Rushton, Caroline Dive, Cassandra L. Hodgkinson, Rhona J. McVey, Henry C Kitchener, Gordon C. Jayson - Cancer Biology & Therapy 2010 被引用: 93